Mucos Pharma CZ

Mucos Pharma CZ is the Czech subsidiary of the German pharmaceutical company Mucos Pharma, a global leader in systemic enzyme therapy. The company specializes in the development and distribution of enzyme-based medicinal products, most notably its flagship brand Wobenzym, which has been used for decades to treat inflammatory conditions. Its therapeutic approach focuses on using combinations of natural enzymes like bromelain, papain, and trypsin to modulate the immune system and accelerate the resolution of inflammation and edema. Following the acquisition of its parent company Atrium Innovations, Mucos Pharma operates as part of the Nestlé Health Science portfolio. The Czech branch serves as a key commercial hub for providing these evidence-based enzyme treatments to the Central European market.